| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 |
|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities | ||||||||
Net loss | ||||||||
-235,329 | -90,733 | -159,457 | -156,079 | 106,110 | 229,312 | 350,830 | 350,934 | 170,787 |
Adjustments to reconcile net loss to cash from operating activities | ||||||||
Derecognition of the TRA liability | ||||||||
0 | 0 | 122,515 | 0 | 0 | - | - | - | - |
Depreciation and amortization | ||||||||
92,800 | 111,292 | 122,102 | 114,215 | 108,962 | 90,041 | 78,226 | 66,215 | 54,581 |
Equity-based compensation expense | ||||||||
11,280 | 10,621 | 13,825 | 15,978 | 28,600 | 38,368 | 7,220 | 0 | 0 |
Goodwill impairment | ||||||||
111,108 | 0 | 0 | - | - | - | - | - | - |
Loss on asset impairments and retirements | ||||||||
40,686 | 0 | 71,942 | 29,881 | 0 | - | - | - | - |
ESPP expense | ||||||||
- | - | - | - | - | - | 0 | - | - |
Amortization of deferred financing costs | ||||||||
371 | 58 | 267 | 164 | 164 | 235 | 129 | 0 | 0 |
Venezuelan currency devaluation charge | ||||||||
- | - | - | - | - | 13,010 | 1,755 | 0 | 0 |
Deferred tax provision (benefit) | ||||||||
727 | -14,634 | 15,543 | -27,536 | 4,868 | -27,995 | -3,621 | -1,449 | 412 |
Reversal of deferred tax assets associated with the TRA | ||||||||
0 | 0 | 46,874 | 0 | 0 | - | - | - | - |
Provision for bad debts | ||||||||
1,281 | 159 | 950 | 11,581 | 228 | -3,137 | 12,551 | -389 | 2,486 |
Loss on disposal of assets | ||||||||
-1,037 | 1,309 | 2,045 | -1,117 | 1,038 | -289 | 39,752 | 2,608 | 47 |
Loss on asset retirement | ||||||||
- | - | - | - | - | 0 | - | - | - |
Changes in fair value of investments | ||||||||
2,747 | -1,199 | 2,627 | 1,123 | -741 | 1,403 | 3,891 | 2,058 | -688 |
Change in value of contingent consideration | ||||||||
- | - | - | - | 1,532 | 0 | 0 | - | - |
Unrealized gain on derivative instruments | ||||||||
-222 | 386 | -634 | -64 | 210 | 0 | 0 | - | - |
Realized loss on sale of investment | ||||||||
0 | 0 | -478 | 0 | 0 | - | - | - | - |
Gain on exchange of investment | ||||||||
- | - | - | - | - | - | - | 3,997 | 0 |
Increase in value of life insurance policies | ||||||||
- | - | - | - | - | - | 815 | -254 | -731 |
Other | ||||||||
1,522 | -843 | 1,876 | 0 | 3,909 | 0 | 0 | - | - |
Changes in operating assets and liabilities | ||||||||
Accounts receivable | ||||||||
-22,152 | 63,654 | -21,271 | -70,388 | -140,657 | 43,349 | 82,032 | 76,729 | 72,266 |
Inventories | ||||||||
10,694 | 2,917 | -12,102 | -27,379 | -41,502 | 30,282 | 85,654 | 1,313 | 4,606 |
Other current assets | ||||||||
-856 | -4,581 | -8,677 | -4,039 | -16,981 | 7,926 | 1,698 | -845 | 2,681 |
Other assets | ||||||||
1,285 | -258 | -674 | 692 | -1,333 | 1,619 | 1,430 | 173 | -403 |
Accounts payable and accrued liabilities | ||||||||
-3,937 | 15,310 | 15,774 | -47,068 | -3,035 | 4,991 | -5,278 | -1,288 | 5,274 |
Deferred revenue | ||||||||
545 | -354 | -13,373 | -39,659 | -18,473 | 13,505 | 39,437 | -11,599 | 2,344 |
Accrued expenses and other current liabilities | ||||||||
- | - | - | - | 3,971 | 32,915 | -2,744 | 20,571 | 21,823 |
Other non-current liabilities | ||||||||
-503 | -2,978 | -4,446 | -13,480 | 1,838 | 5,915 | 6,956 | 4,662 | 1,445 |
Other | ||||||||
- | - | - | - | - | - | - | - | 160 |
Net cash used in operating activities | ||||||||
27,048 | -32,644 | 24,774 | -10,831 | 427,758 | 368,860 | 277,431 | 344,776 | 180,710 |
Cash flows from investing activities | ||||||||
Acquisition of Blackhawk (net of acquired cash) | ||||||||
- | - | - | 150,437 | 0 | 0 | 0 | - | - |
Purchases of property, plant and equipment and intangibles | ||||||||
36,942 | 19,734 | 21,990 | 42,127 | 99,723 | 172,952 | 184,504 | 180,187 | 117,883 |
Purchase of property, plant and equipment from related parties | ||||||||
0 | 36,737 | 0 | 0 | - | - | - | - | - |
Acquisition of Timco Services, Inc. (net of acquired cash) | ||||||||
- | - | - | - | 78,676 | 0 | - | - | - |
Proceeds from sale of assets | ||||||||
791 | 7,089 | 14,030 | 3,858 | 4,579 | 848 | 50,959 | 5,259 | 391 |
Proceeds from sale of investments | ||||||||
46,739 | 143,825 | 53,299 | 11,101 | 0 | 0 | - | - | - |
Purchase of investments | ||||||||
20,122 | 84,040 | 123,048 | 1,003 | 869 | - | - | - | - |
Purchase of marketable securities | ||||||||
- | - | - | - | - | 1,539 | 1,813 | 2,757 | 4,518 |
Other | ||||||||
512 | 0 | 0 | 307 | 0 | 0 | - | 1,760 | 947 |
Premiums on life insurance policies | ||||||||
- | - | - | - | - | - | 2,142 | 3,088 | 3,698 |
Net cash used in investing activities | ||||||||
-10,046 | 10,403 | -77,709 | -178,915 | -174,689 | -173,643 | -137,500 | -182,533 | -126,655 |
Cash flows from financing activities | ||||||||
Proceeds from initial public offering, net of offering costs | ||||||||
- | - | - | - | - | - | 711,511 | 0 | 0 |
Repayments of borrowings | ||||||||
5,627 | 5,892 | 680 | 7,201 | 765 | 72 | 472,070 | 39,211 | 39,735 |
Proceeds from borrowings | ||||||||
- | - | - | 363 | 151 | 0 | 170 | 19,016 | 5,100 |
Dividends paid on common stock | ||||||||
0 | 0 | 50,154 | 79,013 | 92,844 | 69,311 | 11,514 | 0 | 0 |
Dividends paid on preferred stock | ||||||||
- | - | - | 1 | 2 | 1 | 0 | 0 | - |
Proceeds from Issuance of Common Stock | ||||||||
- | - | - | - | - | - | - | - | 2,726 |
Deferred financing costs | ||||||||
184 | 1,733 | 0 | 0 | - | - | 1,000 | 0 | 0 |
Cost of Series A convertible preferred stock conversion to common stock | ||||||||
- | - | - | 595 | 0 | 0 | - | - | - |
Distribution to noncontrolling interest | ||||||||
- | - | - | 8,027 | 43,539 | 41,565 | 11,496 | 0 | 0 |
Treasury shares withheld for taxes | ||||||||
1,886 | 1,636 | 2,901 | 3,264 | 4,497 | 4,801 | 0 | 0 | - |
Proceeds from the issuance of ESPP shares | ||||||||
1,752 | 1,315 | 1,264 | 973 | 287 | 0 | 0 | - | - |
Distributions to stockholders | ||||||||
- | - | - | - | - | - | 105,367 | 87,015 | 39,965 |
Net cash used in financing activities | ||||||||
-5,945 | -7,946 | -52,471 | -96,765 | -141,209 | -115,750 | 110,234 | -107,210 | -71,874 |
Effect of exchange rate changes on cash | ||||||||
-529 | 3,384 | -1,105 | 3,678 | 1,145 | 5,980 | 1,262 | -737 | 2,305 |
Net decrease in cash, cash equivalents and restricted cash | ||||||||
10,528 | -26,803 | -106,511 | -282,833 | 113,005 | 84,407 | 252,002 | 54,296 | -15,514 |
Effect of exchange rate changes on cash due to Venezuelan devaluation | ||||||||
- | - | - | - | - | -1,040 | 575 | 0 | 0 |